Filed: 5/15/2026ACC: 0001193125-26-225480
📋 What this filing means
OMEGA FUND MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 10 equity positions with a total reported market value of $163.15M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$163.15M
Total AUM (reported)
18.77M
Total Shares
Allocation by class
COMMON STOCK$128.48M78.8%
COMMON STOCK CLASS A$34.67M21.2%
Portfolio Concentration
Top 3$111.69M68.5%
4–10$51.46M31.5%
Top 3 weight
68.5%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 18.77M
Sole
Full voting authority
18.77M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole10
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings10
Rows:
Bicara Therapeutics Inc.
SOLEShares2.39M
TypeSH
Market value$47.58M
29.16%
Sole
2.39M
Shared
0.00
None
0.00
Nuvation Bio Inc.
SOLEShares8.08M
TypeSH
Market value$34.67M
21.25%
Sole
8.08M
Shared
0.00
None
0.00
BridgeBio Oncology Therapeutics Inc.
SOLEShares3.29M
TypeSH
Market value$29.44M
18.05%
Sole
3.29M
Shared
0.00
None
0.00
Kestra Med Technologies Ltd
SOLEShares1.02M
TypeSH
Market value$20.37M
12.49%
Sole
1.02M
Shared
0.00
None
0.00
Beta Bionics Inc.
SOLEShares1.32M
TypeSH
Market value$13.19M
8.08%
Sole
1.32M
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares876.36K
TypeSH
Market value$5.97M
3.66%
Sole
876.36K
Shared
0.00
None
0.00
Alumis Inc.
SOLEShares241.25K
TypeSH
Market value$5.31M
3.26%
Sole
241.25K
Shared
0.00
None
0.00
Sana Biotechnology, Inc.
SOLEShares843.75K
TypeSH
Market value$2.43M
1.49%
Sole
843.75K
Shared
0.00
None
0.00
ImageneBio, Inc.
SOLEShares455.36K
TypeSH
Market value$2.28M
1.40%
Sole
455.36K
Shared
0.00
None
0.00
Replimune Group
SOLEShares248.67K
TypeSH
Market value$1.91M
1.17%
Sole
248.67K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Bicara Therapeutics Inc.SOLE | Common Stock | 2.39M | SH | $47.58M 29.16% | 2.39M | 0.00 | 0.00 |
Nuvation Bio Inc.SOLE | Common Stock Class A | 8.08M | SH | $34.67M 21.25% | 8.08M | 0.00 | 0.00 |
BridgeBio Oncology Therapeutics Inc.SOLE | Common Stock | 3.29M | SH | $29.44M 18.05% | 3.29M | 0.00 | 0.00 |
Kestra Med Technologies LtdSOLE | Common Stock | 1.02M | SH | $20.37M 12.49% | 1.02M | 0.00 | 0.00 |
Beta Bionics Inc.SOLE | Common Stock | 1.32M | SH | $13.19M 8.08% | 1.32M | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Common Stock | 876.36K | SH | $5.97M 3.66% | 876.36K | 0.00 | 0.00 |
Alumis Inc.SOLE | Common Stock | 241.25K | SH | $5.31M 3.26% | 241.25K | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $2.43M 1.49% | 843.75K | 0.00 | 0.00 |
ImageneBio, Inc.SOLE | Common Stock | 455.36K | SH | $2.28M 1.40% | 455.36K | 0.00 | 0.00 |
Replimune GroupSOLE | Common Stock | 248.67K | SH | $1.91M 1.17% | 248.67K | 0.00 | 0.00 |